Skip to main content
Industry News
Teva, Iontas enter deal for biotherapeutics development
7/31/2019

Teva Pharmaceuticals and Iontas have partnered to optimize human antibodies to be used for biotherapeutics. Iontas will provide Teva with optimized antibodies for a specific target, with the latter gaining the option to be part of future optimization programs.

Full Story: